Strategy catalog

Compare strategies before you run anything.

Review return, drawdown, required capital, and access in plain language. Start simulated before connecting live execution.

4

Strategies currently accepting users. Metrics are historical/reference only.

Start simulated

01

Accepting users
futures

SOL Carry V1

Low-balance futures carry focused on short holding windows and capital-efficient entries.

futurescarrystarter-friendly
Return
+22.00%
Max DD
-8.50%
Sharpe
2.60

$50.00 minimum · $200,000 left

View strategy

02

Accepting users
spotfutures

ETH Reversion V1

Short-horizon spot and futures reversion with strict cooldown behavior and founder-managed parameters.

spot+futuresmean reversionmulti-symbol
Return
+24.20%
Max DD
-9.35%
Sharpe
2.60

$250.00 minimum · $200,000 left

View strategy

03

Accepting users
futures

Adaptive Trend Overlay

Semimonth adaptive trend overlay running the real paper-mode selection and carry-forward logic from the overlay research stack.

overlaypaper-firstfuturessemimonth
Return
+33.00%
Max DD
-12.75%
Sharpe
2.60

$250.00 minimum · $200,000 left

View strategy

04

Accepting users
spotfutures

BTC Trend V1

Medium-frequency trend participation with spot/futures routing decided by the engine.

trendbtcspot+futures
Return
+26.40%
Max DD
-10.20%
Sharpe
2.60

$500.00 minimum · $200,000 left

View strategy

05

closed to new users
spotfutures

Arb Rotation V1

Cross-market rotation with spot and futures legs managed entirely by the engine boundary contract.

rotationspot+futurescapacity-limited
Return
+28.60%
Max DD
-11.05%
Sharpe
2.60

$1,500 minimum · $200,000 left

View strategy

06

disabled
futures

ADA Breakout V1

Higher-beta breakout profile currently held back from new deployment while founder review continues.

breakoutfuturesreview
Return
+30.80%
Max DD
-11.90%
Sharpe
2.60

$300.00 minimum · $200,000 left

View strategy

Historical metrics are not promised returns. Live automation uses real funds and should be enabled only after MFA, API-key, IP whitelist, billing/trial, and product-capacity checks are complete.